MyNewOptions: An Online Study of Reproductive Life Planning and Contraceptive Action Planning
Study Details
Study Description
Brief Summary
The purpose of this web-based study is to determine whether reproductive life planning (RLP), with or without contraceptive action planning (RLP+), will result in reduced risk of unintended pregnancy when compared to an information-only control group.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Most US families want 2 children, resulting in the average woman spending 3 decades of her life trying to avoid pregnancy. However, most women have at least one unintended pregnancy, resulting in 1.5 million abortions and 1.7 million unintended births annually. Women and couples try to avoid unintended pregnancy for a range of personal, social, and economic reasons, but also due to the increased physical and mental health effects for children that result from unintended pregnancy. Healthcare reform now requires that private health insurance companies cover all FDA-approved contraceptive methods with no copays or deductibles to the patient, creating a great opportunity for women with health insurance to get contraceptive methods they previously could not afford. In this study, women with health insurance will be randomly assigned to one of three groups: (1) Reproductive Life Planning (RLP)-women will complete a reproductive life plan that guides them to think about if and when they would want any future pregnancies, and to determine what contraceptive method(s) are best suited to them; (2) Reproductive Life Planning Plus (RLP+) which additionally includes "if-then planning," where women determine what they will do when they encounter difficult situations that make it difficult to use their contraceptive method perfectly; or (3) an information-only control group. The online format of the study allows for the potential of wide dissemination. The RLP and RLP+ interventions are expected to result in greater likelihood of contraceptive use, continuity of contraceptive use, and contraceptive adherence, and thus reduce overall risk of unintended pregnancy.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Reproductive Life Planning (RLP) RLP is an online adaptation of the Centers for Disease Control and Prevention (CDC) reproductive life planning toll that guides women to identify their reproductive goals and individual requirements for contraception. |
Behavioral: Reproductive Life Planning (RLP)
Behavioral: Contraception information
|
Experimental: Reproductive Life Planning Plus (RLP+) RLP+ additionally includes contraceptive action planning, aimed at helping women select solutions for potential problems they may encounter with contraceptive adherence. |
Behavioral: Reproductive Life Planning (RLP)
Behavioral: Contraceptive Action Planning
Behavioral: Contraception information
|
Active Comparator: Information-only control The information-only control will deliver on-line information about their contraceptive benefits coverage and information about all FDA-approved contraceptive methods. |
Behavioral: Contraception information
|
Outcome Measures
Primary Outcome Measures
- Contraceptive Use [24 months]
Percentage of surveys with any contraceptive use
Secondary Outcome Measures
- Effectiveness of Contraceptive Method [24 months]
Percentage of surveys where most effective contraceptive method used
- Contraceptive Method Satisfaction [24 months]
percentage of surveys where very satisfied with contraceptive method
- Contraceptive Adherence [24 months]
Percentage of surveys where contraceptive adherence was high
Eligibility Criteria
Criteria
Inclusion Criteria:
-
not currently pregnant
-
sexually active with a male partner in the past 6 months OR anticipate being sexually active with a male partner in the next 6 months
-
does not intend pregnancy in the next 12 months
-
has Internet access and email address
Exclusion Criteria:
-
tubal sterilization
-
hysterectomy
-
partner with vasectomy
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Penn State College of Medicine | Hershey | Pennsylvania | United States | 17033 |
Sponsors and Collaborators
- Milton S. Hershey Medical Center
- Patient-Centered Outcomes Research Institute
Investigators
- Principal Investigator: Cynthia H Chuang, MD, MSc, Penn State College of Medicine
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- CD-1304-6117
- CD-1304-6117
Study Results
Participant Flow
Recruitment Details | |
---|---|
Pre-assignment Detail |
Arm/Group Title | Reproductive Life Planning (RLP) | Reproductive Life Planning Plus (RLP+) | Information-only Control |
---|---|---|---|
Arm/Group Description | RLP is an online adaptation of the Centers for Disease Control and Prevention (CDC) reproductive life planning toll that guides women to identify their reproductive goals and individual requirements for contraception. Reproductive Life Planning (RLP) Contraception information | RLP+ additionally includes contraceptive action planning, aimed at helping women select solutions for potential problems they may encounter with contraceptive adherence. Reproductive Life Planning (RLP) Contraceptive Action Planning Contraception information | The information-only control will deliver on-line information about their contraceptive benefits coverage and information about all FDA-approved contraceptive methods. Contraception information |
Period Title: Overall Study | |||
STARTED | 329 | 329 | 326 |
COMPLETED | 323 | 318 | 323 |
NOT COMPLETED | 6 | 11 | 3 |
Baseline Characteristics
Arm/Group Title | Reproductive Life Planning (RLP) | Reproductive Life Planning Plus (RLP+) | Information-only Control | Total |
---|---|---|---|---|
Arm/Group Description | RLP is an online adaptation of the Centers for Disease Control and Prevention (CDC) reproductive life planning toll that guides women to identify their reproductive goals and individual requirements for contraception. Reproductive Life Planning (RLP) Contraception information | RLP+ additionally includes contraceptive action planning, aimed at helping women select solutions for potential problems they may encounter with contraceptive adherence. Reproductive Life Planning (RLP) Contraceptive Action Planning Contraception information | The information-only control will deliver on-line information about their contraceptive benefits coverage and information about all FDA-approved contraceptive methods. Contraception information | Total of all reporting groups |
Overall Participants | 329 | 329 | 326 | 984 |
Age (Count of Participants) | ||||
<=18 years |
0
0%
|
0
0%
|
0
0%
|
0
0%
|
Between 18 and 65 years |
329
100%
|
329
100%
|
326
100%
|
984
100%
|
>=65 years |
0
0%
|
0
0%
|
0
0%
|
0
0%
|
Age (years) [Mean (Standard Deviation) ] | ||||
Mean (Standard Deviation) [years] |
27.02
(5.95)
|
27.08
(6.13)
|
27.28
(5.92)
|
27.13
(5.99)
|
Sex: Female, Male (Count of Participants) | ||||
Female |
329
100%
|
329
100%
|
326
100%
|
984
100%
|
Male |
0
0%
|
0
0%
|
0
0%
|
0
0%
|
Region of Enrollment (participants) [Number] | ||||
United States |
329
100%
|
329
100%
|
326
100%
|
984
100%
|
Outcome Measures
Title | Contraceptive Use |
---|---|
Description | Percentage of surveys with any contraceptive use |
Time Frame | 24 months |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Reproductive Life Planning (RLP) | Reproductive Life Planning Plus (RLP+) | Information-only Control |
---|---|---|---|
Arm/Group Description | RLP is an online adaptation of the Centers for Disease Control and Prevention (CDC) reproductive life planning toll that guides women to identify their reproductive goals and individual requirements for contraception. Reproductive Life Planning (RLP) Contraception information | RLP+ additionally includes contraceptive action planning, aimed at helping women select solutions for potential problems they may encounter with contraceptive adherence. Reproductive Life Planning (RLP) Contraceptive Action Planning Contraception information | The information-only control will deliver on-line information about their contraceptive benefits coverage and information about all FDA-approved contraceptive methods. Contraception information |
Measure Participants | 308 | 298 | 312 |
Mean (Standard Deviation) [percentage of surveys] |
93.43
(20.59)
|
94.46
(20.53)
|
94.10
(19.80)
|
Statistical Analysis 1
Statistical Analysis Overview | Comparison Group Selection | Reproductive Life Planning (RLP), Information-only Control |
---|---|---|
Comments | ||
Type of Statistical Test | Superiority | |
Comments | ||
Statistical Test of Hypothesis | p-Value | 1.0 |
Comments | ||
Method | Regression, Logistic | |
Comments | ||
Method of Estimation | Estimation Parameter | Odds Ratio (OR) |
Estimated Value | 0.87 | |
Confidence Interval |
(2-Sided) 95% 0.56 to 1.36 |
|
Parameter Dispersion |
Type: Value: |
|
Estimation Comments |
Statistical Analysis 2
Statistical Analysis Overview | Comparison Group Selection | Reproductive Life Planning Plus (RLP+), Information-only Control |
---|---|---|
Comments | ||
Type of Statistical Test | Superiority | |
Comments | ||
Statistical Test of Hypothesis | p-Value | 1.0 |
Comments | ||
Method | Regression, Logistic | |
Comments | ||
Method of Estimation | Estimation Parameter | Odds Ratio (OR) |
Estimated Value | 1.13 | |
Confidence Interval |
(2-Sided) 95% 0.70 to 1.83 |
|
Parameter Dispersion |
Type: Value: |
|
Estimation Comments |
Statistical Analysis 3
Statistical Analysis Overview | Comparison Group Selection | Reproductive Life Planning (RLP), Reproductive Life Planning Plus (RLP+) |
---|---|---|
Comments | ||
Type of Statistical Test | Superiority | |
Comments | ||
Statistical Test of Hypothesis | p-Value | 0.53 |
Comments | ||
Method | Regression, Logistic | |
Comments | ||
Method of Estimation | Estimation Parameter | Odds Ratio (OR) |
Estimated Value | 1.30 | |
Confidence Interval |
(2-Sided) 95% 0.82 to 2.08 |
|
Parameter Dispersion |
Type: Value: |
|
Estimation Comments |
Title | Effectiveness of Contraceptive Method |
---|---|
Description | Percentage of surveys where most effective contraceptive method used |
Time Frame | 24 months |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Reproductive Life Planning (RLP) | Reproductive Life Planning Plus (RLP+) | Information-only Control |
---|---|---|---|
Arm/Group Description | RLP is an online adaptation of the Centers for Disease Control and Prevention (CDC) reproductive life planning toll that guides women to identify their reproductive goals and individual requirements for contraception. Reproductive Life Planning (RLP) Contraception information | RLP+ additionally includes contraceptive action planning, aimed at helping women select solutions for potential problems they may encounter with contraceptive adherence. Reproductive Life Planning (RLP) Contraceptive Action Planning Contraception information | The information-only control will deliver on-line information about their contraceptive benefits coverage and information about all FDA-approved contraceptive methods. Contraception information |
Measure Participants | 308 | 298 | 312 |
Mean (Standard Deviation) [percentage of surveys] |
60.66
(45.11)
|
63.93
(43.91)
|
63.19
(43.22)
|
Statistical Analysis 1
Statistical Analysis Overview | Comparison Group Selection | Reproductive Life Planning (RLP), Information-only Control |
---|---|---|
Comments | ||
Type of Statistical Test | Superiority | |
Comments | ||
Statistical Test of Hypothesis | p-Value | 0.48 |
Comments | ||
Method | Regression, Logistic | |
Comments | ||
Method of Estimation | Estimation Parameter | Odds Ratio (OR) |
Estimated Value | 0.88 | |
Confidence Interval |
(2-Sided) 95% 0.71 to 1.09 |
|
Parameter Dispersion |
Type: Value: |
|
Estimation Comments |
Statistical Analysis 2
Statistical Analysis Overview | Comparison Group Selection | Reproductive Life Planning Plus (RLP+), Information-only Control |
---|---|---|
Comments | ||
Type of Statistical Test | Superiority | |
Comments | ||
Statistical Test of Hypothesis | p-Value | 1.0 |
Comments | ||
Method | Regression, Logistic | |
Comments | ||
Method of Estimation | Estimation Parameter | Odds Ratio (OR) |
Estimated Value | 1.08 | |
Confidence Interval |
(2-Sided) 95% 0.87 to 1.35 |
|
Parameter Dispersion |
Type: Value: |
|
Estimation Comments |
Statistical Analysis 3
Statistical Analysis Overview | Comparison Group Selection | Reproductive Life Planning (RLP), Reproductive Life Planning Plus (RLP+) |
---|---|---|
Comments | ||
Type of Statistical Test | Superiority | |
Comments | ||
Statistical Test of Hypothesis | p-Value | 0.07 |
Comments | ||
Method | Regression, Logistic | |
Comments | ||
Method of Estimation | Estimation Parameter | Odds Ratio (OR) |
Estimated Value | 1.23 | |
Confidence Interval |
(2-Sided) 95% 0.99 to 1.53 |
|
Parameter Dispersion |
Type: Value: |
|
Estimation Comments |
Title | Contraceptive Method Satisfaction |
---|---|
Description | percentage of surveys where very satisfied with contraceptive method |
Time Frame | 24 months |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Reproductive Life Planning (RLP) | Reproductive Life Planning Plus (RLP+) | Information-only Control |
---|---|---|---|
Arm/Group Description | RLP is an online adaptation of the Centers for Disease Control and Prevention (CDC) reproductive life planning toll that guides women to identify their reproductive goals and individual requirements for contraception. Reproductive Life Planning (RLP) Contraception information | RLP+ additionally includes contraceptive action planning, aimed at helping women select solutions for potential problems they may encounter with contraceptive adherence. Reproductive Life Planning (RLP) Contraceptive Action Planning Contraception information | The information-only control will deliver on-line information about their contraceptive benefits coverage and information about all FDA-approved contraceptive methods. Contraception information |
Measure Participants | 299 | 289 | 304 |
Mean (Standard Deviation) [percentage of surveys] |
58.22
(39.39)
|
57.09
(41.13)
|
57.70
(39.57)
|
Statistical Analysis 1
Statistical Analysis Overview | Comparison Group Selection | Reproductive Life Planning (RLP), Information-only Control |
---|---|---|
Comments | ||
Type of Statistical Test | Superiority | |
Comments | ||
Statistical Test of Hypothesis | p-Value | 1.0 |
Comments | ||
Method | Regression, Logistic | |
Comments | ||
Method of Estimation | Estimation Parameter | Odds Ratio (OR) |
Estimated Value | 1.04 | |
Confidence Interval |
(2-Sided) 95% 0.84 to 1.29 |
|
Parameter Dispersion |
Type: Value: |
|
Estimation Comments |
Statistical Analysis 2
Statistical Analysis Overview | Comparison Group Selection | Reproductive Life Planning Plus (RLP+), Information-only Control |
---|---|---|
Comments | ||
Type of Statistical Test | Superiority | |
Comments | ||
Statistical Test of Hypothesis | p-Value | 1.0 |
Comments | ||
Method | Regression, Logistic | |
Comments | ||
Method of Estimation | Estimation Parameter | Odds Ratio (OR) |
Estimated Value | 1.02 | |
Confidence Interval |
(2-Sided) 95% 0.82 to 1.26 |
|
Parameter Dispersion |
Type: Value: |
|
Estimation Comments |
Statistical Analysis 3
Statistical Analysis Overview | Comparison Group Selection | Reproductive Life Planning (RLP), Reproductive Life Planning Plus (RLP+) |
---|---|---|
Comments | ||
Type of Statistical Test | Superiority | |
Comments | ||
Statistical Test of Hypothesis | p-Value | 1.0 |
Comments | ||
Method | Regression, Logistic | |
Comments | ||
Method of Estimation | Estimation Parameter | Odds Ratio (OR) |
Estimated Value | 0.98 | |
Confidence Interval |
(2-Sided) 95% 0.79 to 1.22 |
|
Parameter Dispersion |
Type: Value: |
|
Estimation Comments |
Title | Contraceptive Adherence |
---|---|
Description | Percentage of surveys where contraceptive adherence was high |
Time Frame | 24 months |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Reproductive Life Planning (RLP) | Reproductive Life Planning Plus (RLP+) | Information-only Control |
---|---|---|---|
Arm/Group Description | RLP is an online adaptation of the Centers for Disease Control and Prevention (CDC) reproductive life planning toll that guides women to identify their reproductive goals and individual requirements for contraception. Reproductive Life Planning (RLP) Contraception information | RLP+ additionally includes contraceptive action planning, aimed at helping women select solutions for potential problems they may encounter with contraceptive adherence. Reproductive Life Planning (RLP) Contraceptive Action Planning Contraception information | The information-only control will deliver on-line information about their contraceptive benefits coverage and information about all FDA-approved contraceptive methods. Contraception information |
Measure Participants | 299 | 289 | 304 |
Mean (Standard Deviation) [percentage of surveys] |
74.02
(34.19)
|
73.27
(35.54)
|
76.37
(32.69)
|
Statistical Analysis 1
Statistical Analysis Overview | Comparison Group Selection | Reproductive Life Planning (RLP), Information-only Control |
---|---|---|
Comments | ||
Type of Statistical Test | Superiority | |
Comments | ||
Statistical Test of Hypothesis | p-Value | 1.0 |
Comments | ||
Method | Regression, Logistic | |
Comments | ||
Method of Estimation | Estimation Parameter | Odds Ratio (OR) |
Estimated Value | 1.07 | |
Confidence Interval |
(2-Sided) 95% 0.83 to 1.37 |
|
Parameter Dispersion |
Type: Value: |
|
Estimation Comments |
Statistical Analysis 2
Statistical Analysis Overview | Comparison Group Selection | Reproductive Life Planning Plus (RLP+), Information-only Control |
---|---|---|
Comments | ||
Type of Statistical Test | Superiority | |
Comments | ||
Statistical Test of Hypothesis | p-Value | 1.0 |
Comments | ||
Method | Regression, Logistic | |
Comments | ||
Method of Estimation | Estimation Parameter | Odds Ratio (OR) |
Estimated Value | 1.04 | |
Confidence Interval |
(2-Sided) 95% 0.81 to 1.33 |
|
Parameter Dispersion |
Type: Value: |
|
Estimation Comments |
Statistical Analysis 3
Statistical Analysis Overview | Comparison Group Selection | Reproductive Life Planning (RLP), Reproductive Life Planning Plus (RLP+) |
---|---|---|
Comments | ||
Type of Statistical Test | Superiority | |
Comments | ||
Statistical Test of Hypothesis | p-Value | 1.0 |
Comments | ||
Method | Regression, Logistic | |
Comments | ||
Method of Estimation | Estimation Parameter | Odds Ratio (OR) |
Estimated Value | 0.97 | |
Confidence Interval |
(2-Sided) 95% 0.75 to 1.25 |
|
Parameter Dispersion |
Type: Value: |
|
Estimation Comments |
Adverse Events
Time Frame | 1 year, 5 months | |||||
---|---|---|---|---|---|---|
Adverse Event Reporting Description | ||||||
Arm/Group Title | Reproductive Life Planning (RLP) | Reproductive Life Planning Plus (RLP+) | Information-only Control | |||
Arm/Group Description | RLP is an online adaptation of the Centers for Disease Control and Prevention (CDC) reproductive life planning toll that guides women to identify their reproductive goals and individual requirements for contraception. Reproductive Life Planning (RLP) Contraception information | RLP+ additionally includes contraceptive action planning, aimed at helping women select solutions for potential problems they may encounter with contraceptive adherence. Reproductive Life Planning (RLP) Contraceptive Action Planning Contraception information | The information-only control will deliver on-line information about their contraceptive benefits coverage and information about all FDA-approved contraceptive methods. Contraception information | |||
All Cause Mortality |
||||||
Reproductive Life Planning (RLP) | Reproductive Life Planning Plus (RLP+) | Information-only Control | ||||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/329 (0%) | 0/329 (0%) | 0/326 (0%) | |||
Serious Adverse Events |
||||||
Reproductive Life Planning (RLP) | Reproductive Life Planning Plus (RLP+) | Information-only Control | ||||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/329 (0%) | 0/329 (0%) | 0/326 (0%) | |||
Other (Not Including Serious) Adverse Events |
||||||
Reproductive Life Planning (RLP) | Reproductive Life Planning Plus (RLP+) | Information-only Control | ||||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/329 (0%) | 0/329 (0%) | 0/326 (0%) |
Limitations/Caveats
More Information
Certain Agreements
Principal Investigators are NOT employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
Results Point of Contact
Name/Title | Dr. Cynthia Chuang |
---|---|
Organization | Penn State College of Medicine |
Phone | 7175318161 |
CChuang@psu.edu |
- CD-1304-6117
- CD-1304-6117